Infliximab as successful treatment option in a case of adenosine deaminase 2 deficiency
Submitted: 19 December 2022
Accepted: 13 October 2023
Published: 19 December 2023
Accepted: 13 October 2023
Abstract Views: 1022
PDF: 276
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini, Side effects of anti-TNFa therapy in juvenile idiopathic arthritis , Reumatismo: Vol. 58 No. 1 (2006)
- P. Caramaschi, S. Pieropan, A. Volpe, A. Carletto, L.M Bambara, D. Biasi, Sustained response to infliximab treatment in two cases of early rheumatoid arthritis that has been maintained after drug withdrawal , Reumatismo: Vol. 60 No. 3 (2008)
- B. Gharib, A. Ghareh Zadeh Shirazi, E. Moradi, B. Yaghmaei, V. Ziaee, A rare disease with a rare presentation: hemi-atrophy caused by fibromuscular dysplasia in a 27 month old girl , Reumatismo: Vol. 71 No. 1 (2019)
- R. Talotta, F. Rigamonti, T. Letizia, S. Bongiovanni, M.C. Ditto, M. Antivalle, S. Santandrea, F. Atzeni, T. Vago, P. Sarzi-Puttini, Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis , Reumatismo: Vol. 71 No. 1 (2019)
- V. Bruzzese, Diffused suberitrodermic psoriasis induced by infliximab , Reumatismo: Vol. 59 No. 4 (2007)
- F. Tiso, M. Favaro, L. Ciprian, S. Cardarelli, M. Rizzo, M. Tonello, A. Ruffatti, F. Cozzi, Digital ulcers in a cohort of 333 scleroderma patients , Reumatismo: Vol. 59 No. 3 (2007)
- F. Trotta, G. Valentini, Safety of anti-TNFa biological drugs , Reumatismo: Vol. 57 No. s4 (2005)
- C. Ferrone, R. Andracco, M.A. Cimmino, Calcium pyrophosphate deposition disease: clinical manifestations , Reumatismo: Vol. 63 No. 4 (2011): Special issue • Microcrystalline Arthritis
- G. Lapadula, Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases , Reumatismo: Vol. 57 No. s4 (2005)
- Giuseppe D'Alessandro, Maria Rosaria Bianco, Spiridon Politis, Celestino Ferrandina, Giuseppe Rossi, Emanuele Altomare, Case report: AREB in a patient with rheumatoid arthritis treated with methotrexate and infliximab , Reumatismo: Vol. 58 No. 1 (2006)
You may also start an advanced similarity search for this article.